Iranian National Formulary
The Iranian National Formulary (INF) has more than 2,300 molecules registered at the Iran's Ministry of Health, including various strengths and dosage forms. The standards regarding pharmaceutical products in Iran are determined and modified by the Pharmacopeia Council.
A Pharmacy in Iranian city of Nishapur
Iran has adopted a full generic-based National Drug Policy (NDP), with local production of essential drugs and vaccines as one of the main goals.[1] Formalities for approval of a new molecule can take between 1 month and 12 months (maximum), as follows:
- 1 month: for new strength/dosage form of any registered/approved product;
- 3 to 7 months: for any new product to the INF list.
Top 20 drug molecules and sales in Iran
| Molecule | Sales for the first 6 month of 2010 (in Iranian Rials) | |
|---|---|---|
| 1 | INTERFERON | 423,996,630,000 |
| 2 | CEFIXIME | 397,896,015,000 |
| 3 | AMOXICILLIN | 323,624,414,264 |
| 4 | CO-AMOXICLAV | 231,047,948,600 |
| 5 | ACETAMINOPHEN | 210,953,849,492 |
| 6 | ALBUMIN | 210,632,806,000 |
| 7 | DOCETAXEL | 182,924,555,600 |
| 8 | IMIPENEM+CILASTATAIN | 181,099,640,000 |
| 9 | CLOPIDOGREL | 169,915,498,015 |
| 10 | IMMUNE GLOBULIN | 160,575,717,000 |
| 11 | ENOXAPARIN | 145,486,724,600 |
| 12 | CEFALEXIN | 142,499,418,000 |
| 13 | DEXTROSE | 141,272,434,000 |
| 14 | ATORVASTATIN | 132,514,275,600 |
| 15 | PANTOPRAZOL | 130,971,241,400 |
| 16 | SALMETEROL | 127,780,028,000 |
| 17 | SODIUM CHLORIDE | 126,043,613,100 |
| 18 | IBUPROFEN | 125,621,562,500 |
| 19 | RITUXIMAB | 118,690,006,000 |
| 20 | ERYTHROPOIETIN | 110,191,720,000 |
See also
References
- "Health services and pharmaceuticals to Iran". Austrade. Archived from the original on 6 March 2007.
- "Iran Pharma". iran-pharma.blogspot.com. 5 February 2010. Archived from the original on 17 August 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.